A new idea for improving thermal therapy was recently published in PNAS and presented at the AAPM session “Frontiers in Medical Physics,” by the young research assistant Xuangfang (Leo) Ding from Wake Forest University. Using multi-walled carbon nanotubes (MWCN’s – shown above) Ding and his collaborators hope to make guided laser cancer removal safer and more effective.
The treatment injects cancer tumors with MWCN’s, and uses a guided near infrared laser to heat them up and deliver a fatal temperature rise to the cancer cells. The laser pulse is low energy (3 W/cm2) and fast (30 seconds per dose). The team uses Magnetic Resonance Temperature Imaging, MRTI, to identify the tumor and then to monitor the tumor’s temperature as well as the temperature of the surrounding tissue. Trials with mice showed a significant rise in the temperature of the cancer cells injected with the MWCN’s, compared to without. And, the tumors were far less likely to come back.
The treatment can be used non-invasively on superficial tumors like skin cancer, and with minimal invasivity to deeper tumors by inserting a small laser optic fiber into the target as well as the MWCN’s. The exception is lung cancer, where the motion of the tumor would cause too great an error in the MRTI.
Since carbon nanotubes are not approved by the FDA, it’s uncertain when the team can begin clinical trials, and they are still investigating any potential side effects of the MWCN’s.
I was curious if carbon nanotubes have been submitted to the FDA by any organization?
Not sure if they have – Xuangfeng said his group is still searching for potential side effects so perhaps they will try.